Quadrant Capital Group LLC Ironwood Pharmaceuticals Inc Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 767 shares of IRWD stock, worth $3,152. This represents 0.0% of its overall portfolio holdings.

Number of Shares

767

Previous 2,026 62.14%

Holding current value

$3,152

Previous $13,000 76.92%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$3.93 - $7.04 $4,947 - $8,863	-1,259 Reduced 62.14%	767 $3,000
Q2 2024 Aug 12, 2024	SELL	$5.58 - $8.61 $19,959 - $30,797	-3,577 Reduced 63.84%	2,026 $13,000
Q1 2024 May 15, 2024	SELL	$8.32 - $15.45 $24,752 - $45,963	-2,975 Reduced 34.68%	5,603 $48,000
Q4 2023 Feb 08, 2024	BUY	$8.79 - $11.51 $30,738 - $40,250	3,497 Added 68.83%	8,578 $98,000
Q3 2023 Nov 14, 2023	SELL	$8.25 - $11.35 $10,065 - $13,847	-1,220 Reduced 19.36%	5,081 $48,000
Q2 2023 Aug 09, 2023	SELL	$10.1 - $11.6 $3,999 - $4,593	-396 Reduced 5.91%	6,301 $67,000
Q1 2023 May 11, 2023	BUY	$10.37 - $12.56 $39,354 - $47,665	3,795 Added 130.77%	6,697 $70,000
Q4 2022 Feb 10, 2023	SELL	$9.9 - $12.43 $8,573 - $10,764	-866 Reduced 22.98%	2,902 $35,000
Q3 2022 Nov 10, 2022	BUY	$10.14 - $12.38 $36,443 - $44,493	3,594 Added 2065.52%	3,768 $39,000
Q2 2022 Aug 09, 2022	BUY	$11.05 - $12.72 $1,502 - $1,729	136 Added 357.89%	174 $2,000
Q1 2022 May 06, 2022	BUY	$10.61 - $12.88 $169 - $206	16 Added 72.73%	38 $0
Q4 2021 Feb 01, 2022	SELL	$10.86 - $13.95 $868 - $1,116	-80 Reduced 78.43%	22 $0
Q3 2021 Nov 12, 2021	SELL	$11.92 - $13.92 $345 - $403	-29 Reduced 22.14%	102 $1,000
Q2 2021 Aug 09, 2021	SELL	$10.16 - $13.11 $243 - $314	-24 Reduced 15.48%	131 $2,000
Q1 2021 May 12, 2021	BUY	$9.04 - $11.86 $723 - $948	80 Added 106.67%	155 $2,000
Q4 2020 Feb 16, 2021	BUY	$9.05 - $12.2 $678 - $915	75 New	75 $1,000
Q1 2020 May 15, 2020	SELL	$8.58 - $14.01 $4,787 - $7,817	-558 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	558	558 $10,000

Others Institutions Holding IRWD

# of Institutions

239

Shares Held

163M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $630M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Ironwood Pharmaceuticals Inc Transaction History